EDITORIAL SECTION
-
STRATEGY
Strategic Positioning for M&A
The biotechnology sector is characterised by a constant influx of small highly specialised companies
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solutions help reduce contamination risk and lower manual handling
-
CLINICAL TRIALS
Virtual Clinical Trials
Virtual digital and decentralized are all descriptions of the novel ways that using technology changes
-
Bio Pharma
Biosimilars and Biobetters
Biosimilars are biologic medical products that are essentially identical to an original product manufactured
-
MANUFACTURING
Transformative Convergence of AI in Pharmaceutical Manufacturing
The pharmaceutical manufacturing industry is on the cusp of a revolutionary transformation driven by
-
Information Technology
Transformative Impact of Artificial Intelligence on Clinical Trials
Artificial Intelligence AI has rapidly evolved from a futuristic concept to a transformative tool across various industries
-
EXPERT Talk
Advancing Biopharmaceutical Innovation Through Cell Encapsulation and Biomimetic Therapeutic Systems
My interest in biopharmaceutical engineering began during my senior year as an undergraduate For my capstone project I worked on the encapsulation of...
Advisory Board
.webp "Juris Hmelnickis")
.webp "Eiman Shafa")
KNOWLEDGE BANK
-
Articles
Digital Transformation and Innovation in the U.S. Pharmaceutical Industry
Something fundamental has shifted inside American pharmaceutical companies over the past few years The clipboards are gone The manual logbooks have been replaced by sensors dashboards and predictive alerts that flag problems before they happen This shift didnt occur overnight but it has accelerated dramatically as competitive pressure and patient expectations have both risen
-
Techno Trends
FDA Authorises Aletta for Autonomous Blood Collection
The US Food and Drug Administration FDA has authorised Aletta the first standalone robotic device designed to collect blood from a patients arm without handson operator intervention
-
Projects
Cambrex Expands Milan R&D Operations With US$30 Million Investment
Cambrex has begun construction of a new research and development facility at its Profarmico Milano site in Italy supported by a US million investment The initiative is designed
-
Research Insights
CAVE-Onc: Graph-constrained agentic validation for cross-domain contradictions in CDISC oncology submissions
The CDISC Rules Engine CORE provides industrystandard validation for Study Data Tabulation Model SDTM submissions yet its imperative domainscoped architecture cannot express crossdomain contradictions
-
White Papers
Post-Translational Modifications in Drug Discovery: From Molecular Regulation to Clinical Impact
For decades the central dogma of molecular biology has anchored our understanding of cellular function DNA to RNA to protein But this linear view is incomplete A growing body of evidence shows that much of biologys complexity
TOP ARTICLES
-
1
Preclinical Development for Topical Drug Products
Dr. Om Shelke
Preclinical development of topical drug products is crucial for evaluating skin delivery, safety, and efficacy. This article explores contemporary strategies, innovative technologies, patient-centered...
-
2
The Influence of Big Pharma on Healthcare Policies in America: Unraveling the Complex Web
Kate Williamson
This article explores the intricate relationship between Big Pharma and healthcare policies in the United States, unraveling the historical context, lobbying tactics, and policy impact. It delves into...
-
3
Regulatory Affairs Outsourcing: Benefits, Challenges, and Best Practices
Kate Williamson
A major transformation of regulatory compliance to pharma, biotech, and medical device firms is the outsourcing of regulatory activities to meet their needs through the availability of specialized kno...
-
4
Revolutionizing Clinical Research: The Role of Energy-Efficient Trial Sites
Harry Callum
Eco-friendly trial sites are revolutionizing clinical research through their low energy use, low environmental footprint, and increased operating performance. These facilities reduce costs, enhance re...
-
5
Green Chemistry in Pharma: Sustainable Drug Manufacturing
Kate Williamson
Green chemistry in pharmaceutical industry is converting the customary operations to models of sails in drug manufacturing. The green pharmaceutical industry minimizes waste and carbon footprint by ta...
press releasesRead more...
Aptar and Aceso Therapeutics Announce Collaboration to Advance Inhaled Antisense Oligonucleotide Therapy for Cystic Fibrosis
Aptar Pharma a global leader in drug delivery dosing protection technologies and services today announced a collaboration with Aceso Therapeutics a biotech developing novel therapies for cystic fibrosis
Etcamah in combination with a CDK4/6 inhibitor approved in the US for 1st-line advanced HR-positive breast cancer
AstraZenecas Etcamah camizestrant in combination with a cyclindependent kinase CDK inhibitor abemaciclib palbociclib or ribociclib has been approved in the US for the treatment of adult patients
Cipla Announces Exclusive Partnership with Qilu Pharmaceutical for the Licensing and Supply of Biosimilar to Keytruda® (Pembrolizumab) in the US FacebookPinterest
Invagen Pharmaceuticals Inc a wholly owned subsidiary of Cipla Limited BSE NSE CIPLA today announced that it has entered into a strategic partnership with Qilu Pharmaceutical Co Ltd
Fresenius Kabi Launches Generic Sugammadex in Simplist® Ready‑to‑Administer Prefilled Syringe in the U.S.
Fresenius Kabi a global healthcare company part of the Fresenius Group specializing in lifesaving therapies and technologies today announced the US launch of the FDAapproved generic Sugammadex
Events Read more...
09 - 10
Sep 2026iPSC Drug Development Summit
Hyatt Regency Boston Harbour,...
14 - 16
Sep 202614 - 15
Sep 202616th American DDF Summit
Omni Boston Hotel at the Seapo...
15 - 17
Sep 2026COPD Drug Development Summit 2026
Street, Boston, MA 02210, USA
21 - 23
Sep 2026Cell & Gene Therapy World Conference
Miami, Florida, USA
21 - 23
Sep 2026Cancer R&D World Conference
Hilton Garden Inn Miami Dolphi...
22 - 23
Sep 2026PDA Advanced Parenteral Therapeutics & Quality
Illume Hotel Taipei, Taiwan
22 - 24
Sep 2026InsurInnovator Connect Asia
Singapore
LATEST NEWSRead more...
Lupin receives US FDA approval for Modafinil tablets
Lupin has received approval from the US Food and Drug Administration FDA for its Abbreviated New Drug Application ANDA for Modafinil Tablets USP mg and mg
AtomVie opens new radiopharmaceutical manufacturing facility in Ontario
AtomVie Global Radiopharma AtomVie a contract development and manufacturing organisation CDMO specialising in radiopharmaceuticals has opened a new manufacturing facility in Hamilton Ontario
FDA Approves First Drug to Treat Alexander Disease
The US Food and Drug Administration FDA has approved Zanvastro zilganersen injection for the treatment of Alexander disease in paediatric and adult patients It is the first FDAapproved treatment
AbbVie Completes Acquisition of Apogee Therapeutics
AbbVie has completed its acquisition of Apogee Therapeutics bringing the biotechnology company and its pipeline of antibodybased treatments into AbbVie
EpiVax Launches AI-Enhanced Models for Immunogenicity Prediction
EpiVax Inc has launched AIenhanced features for ISPRI its in silico platform for assessing the immunogenicity risk of biotherapeutics The update includes an improved JanusMatrix model
Thermo Fisher Scientific Launches Multiskan™ Ease Absorbance Microplate Reader
Thermo Fisher Scientific has launched the Thermo Scientific Multiskan Ease Absorbance Microplate Reader designed to simplify routine laboratory analysis involving proteins cells and microorganisms
